CTX001

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of Sickle cell disease and B-thalassemi; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders